Oct 21, 2020

Bernard Gilly PhD, CEO and Co-Founder, GenSight Biologics talks about the innovative gene therapy treatments GenSight is developing to fight blinding diseases. Bernard sheds light on treating Leber Hereditary Optic Neuropathy (LHON), a mitochondrial rare disease as well as retinitis pigmentosa (RP). Their goal is to...

Oct 21, 2020

Bernard Gilly PhD, CEO and Co-Founder, GenSight Biologics talks about the innovative gene therapy treatments GenSight is developing to fight blinding diseases. Bernard sheds light on treating Leber Hereditary Optic Neuropathy (LHON), a mitochondrial rare disease as well as retinitis pigmentosa (RP). Their goal is to...

May 30, 2017

Jason Shelton, CEO, Telomere Diagnostics and developer of TeloYears is bringing to market a way to measure the health of the cells in our body.  Using a blood test to determine the length of the telomeres at the end of the chromosomes, a person's TeloYears is computed and compared to others of the same chronological...

Mar 12, 2017

Paul Knoepfler PhD, Professor in the Department of Cell Biology and Human Anatomy, University of California Davis is also the author of the new book GMO Sapiens: The Life-Changing Science of Designer Babies and talks with me about what stem cells can do to help create new cancer therapies as well as grow organoids in...

Mar 8, 2017

Dr. Siddhartha Mukherjee, is assistant professor of medicine at Columbia University, physician at Columbia University Medical Center and author of the Pulitzer Prize winning The Emperor of All Maladies: A Biography of Cancer and the recently published The Gene: An Intimate History.  I heard Sid speak at the 10th...